FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/071738 [Registered on: 31/07/2024] Trial Registered Prospectively
Last Modified On: 19/07/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Study To Know The Burden of Hypertension and its Associated Factors in Patients Attending NIUM Hospital 
Scientific Title of Study   Study on Prevalence of Hypertension with Associated Risk Factors in Patient Attending NIUM Hospital 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Qureshi Rumana Khatoon Jahid Ali 
Designation  PG Scholar 
Affiliation  National Institute of Unani Medicine  
Address  Department of Tahaffuzi wa Samaji Tib National Institute of Unani Medicine, Kottigepalya, Magadi Main Road, Bangalore, Karnataka - 560091.

Bangalore
KARNATAKA
560091
India 
Phone  7848968464  
Fax    
Email  rummanaqureshi8@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof Arish MK Sherwani  
Designation  Prof and HOD 
Affiliation  National Institute of Unani Medicine 
Address  Department of Tahaffuzi wa Samaji Tib National Institute of Unani Medicine, Kottigepalya, Magadi Main Road, Bangalore, Karnataka - 560091.

Bangalore
KARNATAKA
560091
India 
Phone  9448794691  
Fax    
Email  Arish_sherwani@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Dr Qureshi Rumana Khatoon Jahid Ali 
Designation  PG Scholar 
Affiliation  National Institute of Unani Medicine 
Address  Department of Tahaffuzi wa Samaji Tib National Institute of Unani Medicine Kottigepalya, Magadi Main Road Bangalore Karnataka 560091

Bangalore
KARNATAKA
560091
India 
Phone  7848968464  
Fax    
Email  rummanaqureshi8@gmail.com  
 
Source of Monetary or Material Support  
Dept. Tahaffuzi wa Samaji Tib, National Institute of Unani Medicine, Kottigepalya Magadi main road, Bangalore-560091 Karnataka, INDIA  
 
Primary Sponsor  
Name  National Institute of Unani Medicine Bangalore  
Address  Dept. Tahaffuzi wa Samaji Tib, National Institute of Unani Medicine, Kottigepalya, Magadi Main Road, Bangalore-560091, Karnataka, INDIA.  
Type of Sponsor  Other [National institute for researches, prevention and cure in unani system of medicine] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Qureshi Rumana Khatoon Jahid Ali  Hospital of National Institute of Unani Medicine, Bangalore.  Department Of Tahaffuzi Wa Samaji Tib, National Institute of Unani Medicine, kottigepalya, Magadi main road, Bangalore.
Bangalore
KARNATAKA 
7848968464

rummanaqureshi8@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Communication of Decision of Institutional Ethics Committee (IEC) for Biomedical Research   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: I10||Essential (primary) hypertension,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1)Age: 18-65 years
2)Gender: All genders
3)Clinically stable patient
 
 
ExclusionCriteria 
Details  1) Those persons who are not willing to participate
in the study
2) Age: Below 18 years and above 65 years

 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Study the prevalence of the hypertension among patients attending NIUM Hospital, Bengaluru  1 year
 
 
Secondary Outcome  
Outcome  TimePoints 
Study the associated risk factors of hypertension patients attending NIUM Hospital, Bengaluru.  1 year 
 
Target Sample Size   Total Sample Size="120"
Sample Size from India="120" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   12/08/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Hypertension is divided into primary (essential) and secondary hypertension. Primary, idiopathic, or essential (hypertension) It is classified as ‘Essential’ in which cause is generally unknown. 2. Secondary or identifiable hypertension: It is classified as secondary when some other disease process or abnormality is involved in its causation. Prominent among these are diseases of the kidney. (Chronic glomerulonephritis and chronic pyelonephritis) tumor of the adrenal gland, Congenital narrowing of the aorta, toxemia of pregnancy, or other identifiable cause.
purpose: Lack of awareness is one of the major factors leading to the increased prevalence of hypertension in India. Many people are not aware of their hypertension condition; even in some cases, the reason for death remains elusive, as most of the time, people suffering from hypertension do not show any visible symptoms, remain normal, and are diagnosed only after the appearance of a cardiovascular disease or stroke. According to the global burden of disease estimate for 2015, hypertension is the most important cause of mortality. It is estimated that 57% and 24% of stroke and coronary artery disease-related deaths, respectively, are due to hypertension. 4 The purpose of this study is to gain new insights regarding the occurrence of hypertension and related risk factors among adult patients seeking care at NIUM Hospital. We focus on the outpatient population who were seeking care from NIUM Hospital. 6 The sole objective of antihypertensive therapy is to reduce the incidence of adverse cardiovascular events, particularly CHD, stroke, and heart failure. Therefore, there is a need to study the prevalence and presence of Unani clinical manifestations in hypertensive people and to develop awareness of hypertension. Keeping these facts in mind, I decided to conduct a study on the prevalence of hypertension and its associated risk factors in patients attending NIUM Hospital (Bengaluru). 
 Design: Cross sectional analytical study.

 
Close